tokens listlengths 4 93 | entities listlengths 2 18 | events listlengths 1 4 |
|---|---|---|
[
"OBJECTIVE",
":",
"To",
"test",
"the",
"hypothesis",
"that",
"tumor",
"necrosis",
"factor",
"(",
"TNF",
")",
"-",
"alpha",
"may",
"mediate",
"the",
"loss",
"and",
"the",
"dedifferentiation",
"of",
"subcutaneous",
"fat",
"tissue",
"in",
"the",
"insulin",
"-",... | [
{
"id": 0,
"text": "insulin",
"start": 28,
"end": 29,
"type": "treatment"
},
{
"id": 1,
"text": "insulin",
"start": 28,
"end": 29,
"type": "drug"
},
{
"id": 2,
"text": "diabetic",
"start": 34,
"end": 35,
"type": "disorder"
},
{
"id": 3,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 30,
"end": 31
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"An",
"evaluation",
"of",
"ovarian",
"structure",
"and",
"function",
"should",
"be",
"considered",
"in",
"women",
"of",
"reproductive",
"age",
"being",
"treated",
"with",
"valproate",
"for",
"epilepsy",
",",
"especially",
"if",
"they",
"develop",
"menstrual",
"c... | [
{
"id": 0,
"text": "women of reproductive age",
"start": 11,
"end": 15,
"type": "subject"
},
{
"id": 1,
"text": "women",
"start": 11,
"end": 12,
"type": "gender"
},
{
"id": 2,
"text": "reproductive age",
"start": 13,
"end": 15,
"type": "age"
},
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "develop",
"start": 25,
"end": 26
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "gender"
},
{
"entity_id": 2,
... |
[
"Phenobarbital",
"hepatotoxicity",
"in",
"an",
"8",
"-",
"month",
"-",
"old",
"infant",
"."
] | [
{
"id": 0,
"text": "an 8-month-old infant",
"start": 3,
"end": 10,
"type": "subject"
},
{
"id": 1,
"text": "8-month-old infant",
"start": 4,
"end": 10,
"type": "age"
},
{
"id": 2,
"text": "Phenobarbital",
"start": 0,
"end": 1,
"type": "treatment"
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "in",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "age"
},
{
"entity_id": 2,
"role"... |
[
"The",
"authors",
"report",
"a",
"case",
"of",
"Balint",
"syndrome",
"with",
"irreversible",
"posterior",
"leukoencephalopathy",
"on",
"MRI",
"following",
"intrathecal",
"methotrexate",
"and",
"cytarabine",
"."
] | [
{
"id": 0,
"text": "intrathecal methotrexate and cytarabine",
"start": 15,
"end": 19,
"type": "treatment"
},
{
"id": 1,
"text": "intrathecal",
"start": 15,
"end": 16,
"type": "route"
},
{
"id": 2,
"text": "methotrexate",
"start": 16,
"end": 17,
"ty... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "following",
"start": 14,
"end": 15
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "route"
},
{
"entity_id": 2,
... |
[
"According",
"to",
"the",
"Naranjo",
"probability",
"scale",
",",
"flecainide",
"was",
"the",
"probable",
"cause",
"of",
"the",
"patient",
"'",
"s",
"delirium",
";",
"the",
"Horn",
"Drug",
"Interaction",
"Probability",
"Scale",
"indicates",
"a",
"possible",
"p... | [
{
"id": 0,
"text": "flecainide",
"start": 7,
"end": 8,
"type": "treatment"
},
{
"id": 1,
"text": "flecainide",
"start": 7,
"end": 8,
"type": "drug"
},
{
"id": 2,
"text": "flecainide",
"start": 32,
"end": 33,
"type": "drug"
},
{
"id": 3,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "cause",
"start": 11,
"end": 12
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Contact",
"dermatitis",
"due",
"to",
"budesonide",
":",
"report",
"of",
"five",
"cases",
"and",
"review",
"of",
"the",
"Japanese",
"literature",
"."
] | [
{
"id": 0,
"text": "Contact dermatitis",
"start": 0,
"end": 2,
"type": "effect"
},
{
"id": 1,
"text": "budesonide",
"start": 4,
"end": 5,
"type": "treatment"
},
{
"id": 2,
"text": "budesonide",
"start": 4,
"end": 5,
"type": "drug"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "due",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Prolongation",
"of",
"the",
"QT",
"interval",
"observed",
"in",
"a",
"Japanese",
"patient",
"with",
"vivax",
"malaria",
"following",
"treatment",
"with",
"halofantrine",
"."
] | [
{
"id": 0,
"text": "a Japanese patient with vivax malaria",
"start": 7,
"end": 13,
"type": "subject"
},
{
"id": 1,
"text": "Japanese",
"start": 8,
"end": 9,
"type": "race"
},
{
"id": 2,
"text": "Prolongation of the QT interval",
"start": 0,
"end": 5,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "following",
"start": 13,
"end": 14
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "race"
},
{
"entity_id": 2,
... |
[
"We",
"report",
"three",
"cases",
"of",
"severe",
"hepatotoxicity",
"related",
"to",
"benzarone",
",",
"a",
"benzofuran",
"derivative",
"."
] | [
{
"id": 0,
"text": "three cases",
"start": 2,
"end": 4,
"type": "subject"
},
{
"id": 1,
"text": "three",
"start": 2,
"end": 3,
"type": "population"
},
{
"id": 2,
"text": "severe hepatotoxicity",
"start": 5,
"end": 7,
"type": "effect"
},
{
"... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "related",
"start": 7,
"end": 8
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "population"
},
{
"entity_id": 2,
... |
[
"Four",
"patients",
"who",
"manifested",
"symptoms",
"of",
"the",
"antiepileptic",
"drug",
"(",
"AED",
")",
"hypersensitivity",
"syndrome",
"during",
"therapy",
"with",
"carbamazepine",
"are",
"reported",
"."
] | [
{
"id": 0,
"text": "Four patients",
"start": 0,
"end": 2,
"type": "subject"
},
{
"id": 1,
"text": "Four",
"start": 0,
"end": 1,
"type": "population"
},
{
"id": 2,
"text": "hypersensitivity syndrome",
"start": 12,
"end": 14,
"type": "effect"
},
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "symptoms of",
"start": 4,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "population"
},
{
"entity_id": 2... |
[
"Minocycline",
"as",
"a",
"cause",
"of",
"drug",
"-",
"induced",
"autoimmune",
"hepatitis",
"."
] | [
{
"id": 0,
"text": "autoimmune hepatitis",
"start": 8,
"end": 10,
"type": "effect"
},
{
"id": 1,
"text": "Minocycline",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 2,
"text": "Minocycline",
"start": 0,
"end": 1,
"type": "drug"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 7,
"end": 8
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Secondary",
"acute",
"myeloid",
"leukemia",
"after",
"etoposide",
"therapy",
"for",
"haemophagocytic",
"lymphohistiocytosis",
"."
] | [
{
"id": 0,
"text": "Secondary acute myeloid leukemia",
"start": 0,
"end": 4,
"type": "effect"
},
{
"id": 1,
"text": "etoposide therapy",
"start": 5,
"end": 7,
"type": "treatment"
},
{
"id": 2,
"text": "etoposide",
"start": 5,
"end": 6,
"type": "dru... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "after",
"start": 4,
"end": 5
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Allergic",
"contact",
"angioedema",
"to",
"benzoyl",
"peroxide",
"."
] | [
{
"id": 0,
"text": "Allergic contact angioedema",
"start": 0,
"end": 3,
"type": "effect"
},
{
"id": 1,
"text": "benzoyl peroxide",
"start": 4,
"end": 6,
"type": "treatment"
},
{
"id": 2,
"text": "benzoyl peroxide",
"start": 4,
"end": 6,
"type": "dr... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "to",
"start": 3,
"end": 4
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
"... |
[
"A",
"60",
"-",
"year",
"-",
"old",
"white",
"man",
"with",
"chronic",
"bronchitis",
"was",
"noted",
"to",
"develop",
"acute",
"respiratory",
"failure",
"and",
"metabolic",
"acidosis",
"four",
"days",
"after",
"being",
"started",
"on",
"methazolamide",
"(",
... | [
{
"id": 0,
"text": "A 60-year-old white man with chronic bronchitis",
"start": 0,
"end": 11,
"type": "subject"
},
{
"id": 1,
"text": "60-year-old",
"start": 1,
"end": 6,
"type": "age"
},
{
"id": 2,
"text": "white",
"start": 6,
"end": 7,
"type": "ra... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "develop",
"start": 14,
"end": 15
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "age"
},
{
"entity_id": 2,
... |
[
"L",
"-",
"DOPA",
"-",
"induced",
"excessive",
"daytime",
"sleepiness",
"in",
"PD",
":",
"a",
"placebo",
"-",
"controlled",
"case",
"with",
"MSLT",
"assessment",
"."
] | [
{
"id": 0,
"text": "L-DOPA",
"start": 0,
"end": 3,
"type": "treatment"
},
{
"id": 1,
"text": "DOPA",
"start": 2,
"end": 3,
"type": "drug"
},
{
"id": 2,
"text": "daytime sleepiness",
"start": 6,
"end": 8,
"type": "effect"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 4,
"end": 5
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"CONCLUSIONS",
":",
"It",
"is",
"probable",
"that",
"foscarnet",
"contributed",
"to",
"the",
"electrolyte",
"disorders",
"and",
"symptomatology",
"in",
"this",
"patient",
"."
] | [
{
"id": 0,
"text": "foscarnet",
"start": 6,
"end": 7,
"type": "treatment"
},
{
"id": 1,
"text": "foscarnet",
"start": 6,
"end": 7,
"type": "drug"
},
{
"id": 2,
"text": "electrolyte disorders and symptomatology",
"start": 10,
"end": 14,
"type": "eff... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "contributed",
"start": 7,
"end": 8
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Acute",
"drug",
"induced",
"hepatitis",
"due",
"to",
"erlotinib",
"."
] | [
{
"id": 0,
"text": "Acute drug induced hepatitis",
"start": 0,
"end": 4,
"type": "effect"
},
{
"id": 1,
"text": "erlotinib",
"start": 6,
"end": 7,
"type": "treatment"
},
{
"id": 2,
"text": "erlotinib",
"start": 6,
"end": 7,
"type": "drug"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "due",
"start": 4,
"end": 5
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"We",
"observed",
"3",
"diabetic",
"patients",
"with",
"intolerable",
"dizziness",
"followed",
"by",
"nausea",
"and",
"vomiting",
"immediately",
"after",
"an",
"initial",
"administration",
"of",
"the",
"alpha",
"-",
"glucosidase",
"inhibitor",
",",
"voglibose",
".... | [
{
"id": 0,
"text": "3 diabetic patients",
"start": 2,
"end": 5,
"type": "subject"
},
{
"id": 1,
"text": "3",
"start": 2,
"end": 3,
"type": "population"
},
{
"id": 2,
"text": "intolerable dizziness followed by nausea and vomiting",
"start": 6,
"end": 13... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "after",
"start": 14,
"end": 15
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "population"
},
{
"entity_id": 2,
... |
[
"Although",
"risk",
"factors",
"for",
"MTX",
"-",
"induced",
"pulmonary",
"toxicity",
"are",
"poorly",
"understood",
",",
"the",
"presence",
"in",
"3",
"out",
"of",
"5",
"of",
"our",
"patients",
"of",
"pre",
"-",
"existing",
"lung",
"disease",
",",
"repres... | [
{
"id": 0,
"text": "MTX",
"start": 4,
"end": 5,
"type": "treatment"
},
{
"id": 1,
"text": "MTX",
"start": 4,
"end": 5,
"type": "drug"
},
{
"id": 2,
"text": "pulmonary toxicity",
"start": 7,
"end": 9,
"type": "effect"
},
{
"id": 3,
"text... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 6,
"end": 7
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Acute",
"esmolol",
"toxicity",
"may",
"be",
"self",
"-",
"limiting",
"because",
"of",
"its",
"extremely",
"short",
"half",
"-",
"life",
"."
] | [
{
"id": 0,
"text": "esmolol",
"start": 1,
"end": 2,
"type": "treatment"
},
{
"id": 1,
"text": "esmolol",
"start": 1,
"end": 2,
"type": "drug"
},
{
"id": 2,
"text": "toxicity",
"start": 2,
"end": 3,
"type": "effect"
},
{
"id": 3,
"text":... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "be",
"start": 4,
"end": 5
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
"ro... |
[
"The",
"association",
"with",
"prolonged",
"unopposed",
"estrogen",
"-",
"like",
"stimulation",
"with",
"tamoxifen",
"as",
"a",
"possible",
"factor",
"in",
"the",
"development",
"of",
"ovarian",
"endometrioid",
"carcinoma",
"is",
"discussed",
"."
] | [
{
"id": 0,
"text": "development of ovarian endometrioid carcinoma",
"start": 17,
"end": 22,
"type": "effect"
},
{
"id": 1,
"text": "prolonged unopposed estrogen-like stimulation with tamoxifen",
"start": 3,
"end": 11,
"type": "treatment"
},
{
"id": 2,
"text": ... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "with",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"The",
"other",
"woman",
"had",
"rheumatoid",
"arthritis",
"and",
"developed",
"acute",
"tubular",
"necrosis",
"after",
"treatment",
"with",
"gentamicin",
"and",
"cefoxitin",
"."
] | [
{
"id": 0,
"text": "acute tubular necrosis",
"start": 8,
"end": 11,
"type": "effect"
},
{
"id": 1,
"text": "The other woman had rheumatoid arthritis",
"start": 0,
"end": 6,
"type": "subject"
},
{
"id": 2,
"text": "woman",
"start": 2,
"end": 3,
"typ... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "developed",
"start": 7,
"end": 8
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "subject"
},
{
"entity_id": 2,
... |
[
"One",
"patient",
"who",
"received",
"clindamycin",
"had",
"liver",
"biopsy",
"findings",
"of",
"marked",
"cholestasis",
",",
"portal",
"inflammation",
",",
"bile",
"duct",
"injury",
"and",
"bile",
"duct",
"paucity",
"(",
"ductopenia",
")",
"."
] | [
{
"id": 0,
"text": "clindamycin",
"start": 4,
"end": 5,
"type": "treatment"
},
{
"id": 1,
"text": "clindamycin",
"start": 4,
"end": 5,
"type": "drug"
},
{
"id": 2,
"text": "One patient",
"start": 0,
"end": 2,
"type": "subject"
},
{
"id": 3,... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "had",
"start": 5,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
"r... |
[
"A",
"MEDLINE",
"search",
"(",
"1966",
"-",
"January",
"2009",
")",
"revealed",
"one",
"in",
"vivo",
"pharmacokinetic",
"study",
"on",
"the",
"interaction",
"between",
"flecainide",
",",
"a",
"CYP2D6",
"substrate",
",",
"and",
"paroxetine",
",",
"a",
"CYP2D6... | [
{
"id": 0,
"text": "flecainide",
"start": 39,
"end": 40,
"type": "treatment"
},
{
"id": 1,
"text": "flecainide",
"start": 39,
"end": 40,
"type": "drug"
},
{
"id": 2,
"text": "delirium",
"start": 42,
"end": 43,
"type": "effect"
},
{
"id": 3,... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 41,
"end": 42
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"As",
"these",
"cases",
"revealed",
",",
"close",
"monitoring",
"of",
"blood",
"chemistry",
"is",
"mandatory",
"after",
"starting",
"spironolactone",
",",
"and",
"patients",
"should",
"be",
"advised",
"to",
"stop",
"spironolactone",
"immediately",
"if",
"diarrhoea... | [
{
"id": 0,
"text": "spironolactone",
"start": 14,
"end": 15,
"type": "treatment"
},
{
"id": 1,
"text": "spironolactone",
"start": 14,
"end": 15,
"type": "drug"
},
{
"id": 2,
"text": "diarrhoea",
"start": 26,
"end": 27,
"type": "effect"
},
{
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "develops",
"start": 27,
"end": 28
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"When",
"these",
"cells",
"are",
"exposed",
"to",
"nicotinic",
"acid",
",",
"an",
"exaggerated",
"immune",
"response",
"is",
"produced",
"that",
"may",
"lead",
"to",
"pain",
",",
"redness",
",",
"and",
"swelling",
"at",
"the",
"injection",
"site",
"."
] | [
{
"id": 0,
"text": "nicotinic acid",
"start": 6,
"end": 8,
"type": "treatment"
},
{
"id": 1,
"text": "nicotinic acid",
"start": 6,
"end": 8,
"type": "drug"
},
{
"id": 2,
"text": "exaggerated immune response",
"start": 10,
"end": 13,
"type": "effect... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "produced",
"start": 14,
"end": 15
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"A",
"case",
"of",
"heatstroke",
"is",
"reported",
"in",
"a",
"32",
"-",
"year",
"-",
"old",
"man",
"diagnosed",
"with",
"schizophrenia",
"and",
"on",
"clozapine",
"monotherapy",
"."
] | [
{
"id": 0,
"text": "heatstroke",
"start": 3,
"end": 4,
"type": "effect"
},
{
"id": 1,
"text": "clozapine monotherapy",
"start": 19,
"end": 21,
"type": "treatment"
},
{
"id": 2,
"text": "clozapine",
"start": 19,
"end": 20,
"type": "drug"
},
{
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "reported",
"start": 5,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Paraplegia",
"following",
"intrathecal",
"cytosine",
"arabinoside",
"."
] | [
{
"id": 0,
"text": "Paraplegia",
"start": 0,
"end": 1,
"type": "effect"
},
{
"id": 1,
"text": "intrathecal cytosine arabinoside",
"start": 2,
"end": 5,
"type": "treatment"
},
{
"id": 2,
"text": "intrathecal",
"start": 2,
"end": 3,
"type": "route"
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "following",
"start": 1,
"end": 2
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Cimetidine",
"-",
"induced",
"fever",
"."
] | [
{
"id": 0,
"text": "Cimetidine",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 1,
"text": "Cimetidine",
"start": 0,
"end": 1,
"type": "drug"
},
{
"id": 2,
"text": "fever",
"start": 3,
"end": 4,
"type": "effect"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"This",
"case",
"report",
"illustrates",
"the",
"neurotoxicity",
"unique",
"to",
"HDARAC",
"."
] | [
{
"id": 0,
"text": "HDARAC",
"start": 8,
"end": 9,
"type": "treatment"
},
{
"id": 1,
"text": "HDARAC",
"start": 8,
"end": 9,
"type": "drug"
},
{
"id": 2,
"text": "This case",
"start": 0,
"end": 2,
"type": "subject"
},
{
"id": 3,
"text":... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "to",
"start": 7,
"end": 8
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
"ro... |
[
"Agranulocytosis",
"associated",
"with",
"ticlopidine",
":",
"a",
"possible",
"benefit",
"with",
"filgastim",
"."
] | [
{
"id": 0,
"text": "ticlopidine",
"start": 3,
"end": 4,
"type": "treatment"
},
{
"id": 1,
"text": "ticlopidine",
"start": 3,
"end": 4,
"type": "drug"
},
{
"id": 2,
"text": "Agranulocytosis",
"start": 0,
"end": 1,
"type": "effect"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "associated",
"start": 1,
"end": 2
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Since",
"SS",
"is",
"a",
"clinical",
"diagnosis",
",",
"heightened",
"clinician",
"awareness",
"of",
"the",
"possibility",
"of",
"SS",
"among",
"patients",
"receiving",
"SSRI",
"or",
"mirtazapine",
"in",
"combination",
"with",
"opioids",
"may",
"lead",
"to",
... | [
{
"id": 0,
"text": "potentially lethal consequences",
"start": 33,
"end": 36,
"type": "effect"
},
{
"id": 1,
"text": "patients",
"start": 16,
"end": 17,
"type": "subject"
},
{
"id": 2,
"text": "SSRI or mirtazapine in combination with opioids",
"start": 18,... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "lead to",
"start": 26,
"end": 28
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "subject"
},
{
"entity_id": 2,
... |
[
"The",
"mechanism",
"by",
"which",
"sunitinib",
"induces",
"gynaecomastia",
"is",
"thought",
"to",
"be",
"associated",
"with",
"an",
"unknown",
"direct",
"action",
"on",
"breast",
"hormonal",
"receptors",
"."
] | [
{
"id": 0,
"text": "sunitinib",
"start": 4,
"end": 5,
"type": "treatment"
},
{
"id": 1,
"text": "sunitinib",
"start": 4,
"end": 5,
"type": "drug"
},
{
"id": 2,
"text": "gynaecomastia",
"start": 6,
"end": 7,
"type": "effect"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induces",
"start": 5,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Some",
"patients",
"develop",
"hypersensitivity",
"rash",
"in",
"response",
"to",
"HCQ",
"."
] | [
{
"id": 0,
"text": "Some patients",
"start": 0,
"end": 2,
"type": "subject"
},
{
"id": 1,
"text": "Some",
"start": 0,
"end": 1,
"type": "population"
},
{
"id": 2,
"text": "hypersensitivity rash",
"start": 3,
"end": 5,
"type": "effect"
},
{
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "develop",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "population"
},
{
"entity_id": 2,
... |
[
"To",
"report",
"a",
"case",
"of",
"serotonin",
"toxicity",
",",
"presenting",
"in",
"the",
"postoperative",
"period",
",",
"caused",
"by",
"an",
"interaction",
"between",
"paroxetine",
"(",
"a",
"selective",
"serotonin",
"reuptake",
"inhibitor",
",",
"SSRI",
... | [
{
"id": 0,
"text": "serotonin toxicity",
"start": 5,
"end": 7,
"type": "effect"
},
{
"id": 1,
"text": "paroxetine",
"start": 19,
"end": 20,
"type": "treatment"
},
{
"id": 2,
"text": "fentanyl",
"start": 30,
"end": 31,
"type": "treatment"
},
{
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "caused",
"start": 14,
"end": 15
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"However",
",",
"to",
"our",
"knowledge",
",",
"in",
"newborns",
"there",
"have",
"been",
"no",
"reported",
"cases",
"to",
"date",
"of",
"thrombocytosis",
"induced",
"by",
"enoxaparin",
"."
] | [
{
"id": 0,
"text": "newborns",
"start": 7,
"end": 8,
"type": "subject"
},
{
"id": 1,
"text": "newborns",
"start": 7,
"end": 8,
"type": "age"
},
{
"id": 2,
"text": "thrombocytosis",
"start": 17,
"end": 18,
"type": "effect"
},
{
"id": 3,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 18,
"end": 19
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "age"
},
{
"entity_id": 2,
... |
[
"The",
"case",
"presented",
"here",
"documents",
"adverse",
"cardiac",
"effects",
"in",
"a",
"28",
"-",
"year",
"-",
"old",
"man",
"who",
"intentionally",
"ingested",
"24",
"mg",
"of",
"risperidone",
"-",
"-",
"4",
"times",
"the",
"recommended",
"dose",
".... | [
{
"id": 0,
"text": "adverse cardiac effects",
"start": 5,
"end": 8,
"type": "effect"
},
{
"id": 1,
"text": "28-year-old man",
"start": 10,
"end": 16,
"type": "subject"
},
{
"id": 2,
"text": "28-year-old",
"start": 10,
"end": 15,
"type": "age"
},
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "ingested",
"start": 18,
"end": 19
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "subject"
},
{
"entity_id": 2,
... |
[
"Anaphylaxis",
"to",
"cisplatin",
"following",
"nine",
"previous",
"uncomplicated",
"cycles",
"."
] | [
{
"id": 0,
"text": "Anaphylaxis",
"start": 0,
"end": 1,
"type": "effect"
},
{
"id": 1,
"text": "cisplatin following nine previous uncomplicated cycles",
"start": 2,
"end": 8,
"type": "treatment"
},
{
"id": 2,
"text": "cisplatin",
"start": 2,
"end": 3,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "to",
"start": 1,
"end": 2
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
"... |
[
"To",
"the",
"best",
"of",
"the",
"authors",
"'",
"knowledge",
",",
"this",
"is",
"the",
"first",
"reported",
"case",
"of",
"Propecia",
"-",
"associated",
"cataract",
"."
] | [
{
"id": 0,
"text": "Propecia",
"start": 16,
"end": 17,
"type": "treatment"
},
{
"id": 1,
"text": "Propecia",
"start": 16,
"end": 17,
"type": "drug"
},
{
"id": 2,
"text": "cataract",
"start": 19,
"end": 20,
"type": "effect"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "associated",
"start": 18,
"end": 19
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Serotonin",
"syndrome",
"caused",
"by",
"interaction",
"between",
"citalopram",
"and",
"fentanyl",
"."
] | [
{
"id": 0,
"text": "Serotonin syndrome",
"start": 0,
"end": 2,
"type": "effect"
},
{
"id": 1,
"text": "citalopram and fentanyl",
"start": 6,
"end": 9,
"type": "treatment"
},
{
"id": 2,
"text": "citalopram",
"start": 6,
"end": 7,
"type": "drug"
},... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "caused",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"We",
"report",
"on",
"three",
"observations",
"of",
"parkinsonian",
"patients",
"with",
"levo",
"-",
"dopa",
"-",
"induced",
"diphasic",
"dyskinesias",
",",
"who",
"received",
"subcutaneous",
"apomorphine",
"to",
"reduce",
"the",
"duration",
"of",
"abnormal",
"... | [
{
"id": 0,
"text": "levo-dopa",
"start": 9,
"end": 12,
"type": "treatment"
},
{
"id": 1,
"text": "levo-dopa",
"start": 9,
"end": 12,
"type": "drug"
},
{
"id": 2,
"text": "diphasic dyskinesias",
"start": 14,
"end": 16,
"type": "effect"
},
{
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 13,
"end": 14
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"This",
"report",
"presents",
"a",
"case",
"of",
"acute",
"lung",
"injury",
"developing",
"within",
"hours",
"after",
"administration",
"of",
"mefloquine",
"for",
"a",
"low",
"-",
"level",
"Plasmodium",
"falciparum",
"malaria",
",",
"which",
"was",
"persistent",... | [
{
"id": 0,
"text": "acute lung injury",
"start": 6,
"end": 9,
"type": "effect"
},
{
"id": 1,
"text": "persistent despite halofantrine therapy",
"start": 27,
"end": 31,
"type": "effect"
},
{
"id": 2,
"text": "administration of mefloquine for a low-level Plasmod... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "after",
"start": 12,
"end": 13
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "effect"
},
{
"entity_id": 2,
... |
[
"Warfarin",
"-",
"associated",
"bleeding",
"generally",
"is",
"considered",
"deleterious",
";",
"however",
",",
"in",
"our",
"patient",
"it",
"unmasked",
"an",
"early",
"stage",
"of",
"colon",
"cancer",
"and",
"thus",
"may",
"have",
"saved",
"the",
"patient",
... | [
{
"id": 0,
"text": "Warfarin",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 1,
"text": "Warfarin",
"start": 0,
"end": 1,
"type": "drug"
},
{
"id": 2,
"text": "bleeding",
"start": 3,
"end": 4,
"type": "effect"
},
{
"id": 3,
"text... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "associated",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"The",
"clinical",
"use",
"of",
"itraconazole",
"in",
"patients",
"receiving",
"multiple",
"doses",
"of",
"oxycodone",
"for",
"pain",
"relief",
"may",
"increase",
"the",
"risk",
"of",
"opioid",
"-",
"associated",
"adverse",
"effects",
"."
] | [
{
"id": 0,
"text": "itraconazole",
"start": 4,
"end": 5,
"type": "treatment"
},
{
"id": 1,
"text": "receiving multiple doses of oxycodone",
"start": 7,
"end": 12,
"type": "treatment"
},
{
"id": 2,
"text": "pain relief",
"start": 13,
"end": 15,
"typ... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "increase",
"start": 16,
"end": 17
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2... |
[
"Three",
"cases",
"of",
"gold",
"-",
"related",
"neuropathy",
"are",
"reported",
"."
] | [
{
"id": 0,
"text": "gold",
"start": 3,
"end": 4,
"type": "treatment"
},
{
"id": 1,
"text": "gold",
"start": 3,
"end": 4,
"type": "drug"
},
{
"id": 2,
"text": "neuropathy",
"start": 6,
"end": 7,
"type": "effect"
},
{
"id": 3,
"text": "Th... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "related",
"start": 5,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"We",
"report",
"the",
"case",
"of",
"a",
"man",
",",
"treated",
"with",
"mesalazine",
"for",
"Crohn",
"'",
"s",
"disease",
"who",
"developed",
"drug",
"-",
"induced",
"pericarditis",
"."
] | [
{
"id": 0,
"text": "drug-induced pericarditis",
"start": 18,
"end": 22,
"type": "effect"
},
{
"id": 1,
"text": "a man",
"start": 5,
"end": 7,
"type": "subject"
},
{
"id": 2,
"text": "man",
"start": 6,
"end": 7,
"type": "gender"
},
{
"id": 3... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "developed",
"start": 17,
"end": 18
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "subject"
},
{
"entity_id": 2,
... |
[
"We",
"report",
"the",
"occurrence",
"of",
"spontaneous",
"intracranial",
"bleeding",
"in",
"an",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"-",
"infected",
"adolescent",
"with",
"hemophilia",
"A",
"who",
"was",
"receiving",
"amprenavir",
"(",
"APV"... | [
{
"id": 0,
"text": "spontaneous intracranial bleeding",
"start": 5,
"end": 8,
"type": "effect"
},
{
"id": 1,
"text": "an human immunodeficiency virus (HIV)-infected adolescent with hemophilia A",
"start": 9,
"end": 22,
"type": "subject"
},
{
"id": 2,
"text": "... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "occurrence",
"start": 3,
"end": 4
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "subject"
},
{
"entity_id": 2,
... |
[
"Under",
"the",
"suspicion",
"of",
"amiodarone",
"-",
"induced",
"acute",
"pancreatitis",
",",
"amiodarone",
"was",
"substituted",
"by",
"propafenone",
"."
] | [
{
"id": 0,
"text": "amiodarone",
"start": 4,
"end": 5,
"type": "treatment"
},
{
"id": 1,
"text": "amiodarone",
"start": 4,
"end": 5,
"type": "drug"
},
{
"id": 2,
"text": "acute pancreatitis",
"start": 7,
"end": 9,
"type": "effect"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 6,
"end": 7
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Evidence",
"is",
"shown",
"in",
"this",
"report",
"that",
"adenosine",
"was",
"associated",
"with",
"dangerous",
"worsening",
"of",
"arrhythmia",
"in",
"patients",
"with",
"atrial",
"flutter",
"."
] | [
{
"id": 0,
"text": "dangerous worsening of arrhythmia",
"start": 11,
"end": 15,
"type": "effect"
},
{
"id": 1,
"text": "patients with atrial flutter",
"start": 16,
"end": 20,
"type": "subject"
},
{
"id": 2,
"text": "adenosine",
"start": 7,
"end": 8,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "associated",
"start": 9,
"end": 10
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "subject"
},
{
"entity_id": 2,
... |
[
"Salicylate",
"hepato",
"toxicity",
"in",
"rheumatic",
"fever",
"."
] | [
{
"id": 0,
"text": "Salicylate",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 1,
"text": "rheumatic fever",
"start": 4,
"end": 6,
"type": "disorder"
},
{
"id": 2,
"text": "Salicylate",
"start": 0,
"end": 1,
"type": "drug"
},
{
"id":... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "toxicity",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "disorder"
},
{
"entity_id": 2,
... |
[
"A",
"case",
"of",
"serotonin",
"syndrome",
"that",
"developed",
"during",
"concurrent",
"linezolid",
"and",
"fluoxetine",
"is",
"presented",
"."
] | [
{
"id": 0,
"text": "concurrent linezolid and fluoxetine",
"start": 8,
"end": 12,
"type": "treatment"
},
{
"id": 1,
"text": "linezolid",
"start": 9,
"end": 10,
"type": "drug"
},
{
"id": 2,
"text": "fluoxetine",
"start": 11,
"end": 12,
"type": "drug"... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "developed",
"start": 6,
"end": 7
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Herein",
"we",
"report",
"four",
"patients",
"who",
"underwent",
"liver",
"transplantation",
"and",
"developed",
"neutropenia",
"while",
"receiving",
"MMF",
"."
] | [
{
"id": 0,
"text": "MMF",
"start": 14,
"end": 15,
"type": "treatment"
},
{
"id": 1,
"text": "MMF",
"start": 14,
"end": 15,
"type": "drug"
},
{
"id": 2,
"text": "neutropenia",
"start": 11,
"end": 12,
"type": "effect"
},
{
"id": 3,
"text"... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "developed",
"start": 10,
"end": 11
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"A",
"study",
"of",
"in",
"vitro",
"reactivity",
"to",
"L",
"-",
"T4",
",",
"as",
"assessed",
"by",
"peripheral",
"blood",
"lymphocyte",
"transformation",
",",
"was",
"carried",
"out",
"in",
"a",
"patient",
"with",
"Hashimoto",
"'",
"s",
"disease",
"who",
... | [
{
"id": 0,
"text": "leukopenia",
"start": 32,
"end": 33,
"type": "effect"
},
{
"id": 1,
"text": "a patient with Hashimoto's disease",
"start": 23,
"end": 30,
"type": "subject"
},
{
"id": 2,
"text": "L-T4",
"start": 36,
"end": 39,
"type": "treatment... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "developed",
"start": 31,
"end": 32
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "subject"
},
{
"entity_id": 2,
... |
[
"Methemoglobinemia",
"is",
"another",
"common",
"finding",
"among",
"patients",
"receiving",
"dapsone",
"therapy",
",",
"but",
"rarely",
"does",
"it",
"result",
"in",
"prominent",
"symptoms",
"other",
"than",
"transient",
"pallor",
"."
] | [
{
"id": 0,
"text": "dapsone therapy",
"start": 8,
"end": 10,
"type": "treatment"
},
{
"id": 1,
"text": "dapsone",
"start": 8,
"end": 9,
"type": "drug"
},
{
"id": 2,
"text": "patients",
"start": 6,
"end": 7,
"type": "subject"
},
{
"id": 3,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "receiving",
"start": 7,
"end": 8
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"During",
"the",
"first",
"treatment",
",",
"dysarthria",
"and",
"ataxia",
"were",
"seen",
"after",
"completion",
"of",
"the",
"patient",
"'",
"s",
"eighth",
"and",
"final",
"dose",
"of",
"HDARAC",
"."
] | [
{
"id": 0,
"text": "dysarthria and ataxia",
"start": 5,
"end": 8,
"type": "effect"
},
{
"id": 1,
"text": "HDARAC",
"start": 22,
"end": 23,
"type": "treatment"
},
{
"id": 2,
"text": "HDARAC",
"start": 22,
"end": 23,
"type": "drug"
},
{
"id":... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "seen",
"start": 9,
"end": 10
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Four",
"weeks",
"earlier",
"she",
"had",
"developed",
"hepatopathy",
"during",
"a",
"regimen",
"of",
"carbamazepine",
",",
"lynestrenol",
"and",
"sodium",
"valproate",
"."
] | [
{
"id": 0,
"text": "she",
"start": 3,
"end": 4,
"type": "subject"
},
{
"id": 1,
"text": "she",
"start": 3,
"end": 4,
"type": "gender"
},
{
"id": 2,
"text": "hepatopathy",
"start": 6,
"end": 7,
"type": "effect"
},
{
"id": 3,
"text": "car... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "developed",
"start": 5,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "gender"
},
{
"entity_id": 2,
... |
[
"We",
"consider",
"asterixis",
"to",
"be",
"an",
"easily",
"overlooked",
"sign",
"of",
"neurotoxicity",
",",
"which",
"may",
"occur",
"even",
"at",
"low",
"or",
"moderate",
"dosage",
"levels",
",",
"if",
"certain",
"drugs",
"as",
"lithium",
"or",
"clozapine"... | [
{
"id": 0,
"text": "even at low or moderate dosage levels",
"start": 15,
"end": 22,
"type": "treatment"
},
{
"id": 1,
"text": "certain drugs as lithium or clozapine are used in combination with CBZ",
"start": 24,
"end": 36,
"type": "treatment"
},
{
"id": 2,
"t... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "occur",
"start": 14,
"end": 15
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"We",
"report",
"here",
"a",
"rare",
"case",
"of",
"pleuropericarditis",
"due",
"to",
"methotrexate",
"."
] | [
{
"id": 0,
"text": "pleuropericarditis",
"start": 7,
"end": 8,
"type": "effect"
},
{
"id": 1,
"text": "methotrexate",
"start": 10,
"end": 11,
"type": "treatment"
},
{
"id": 2,
"text": "methotrexate",
"start": 10,
"end": 11,
"type": "drug"
},
{
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "due",
"start": 8,
"end": 9
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"A",
"case",
"of",
"phenytoin",
"-",
"induced",
"hepatitis",
"with",
"mononucleosis",
"is",
"reported",
",",
"and",
"syndromes",
"associated",
"with",
"phenytoin",
"hypersensitivity",
"reactions",
"are",
"discussed",
"."
] | [
{
"id": 0,
"text": "phenytoin",
"start": 3,
"end": 4,
"type": "treatment"
},
{
"id": 1,
"text": "phenytoin",
"start": 3,
"end": 4,
"type": "drug"
},
{
"id": 2,
"text": "hepatitis with mononucleosis",
"start": 6,
"end": 9,
"type": "effect"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 5,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"We",
"also",
"discuss",
"whether",
"screening",
"for",
"DPD",
"deficiency",
"is",
"warranted",
"to",
"identify",
"patients",
"at",
"risk",
"for",
"severe",
"toxicities",
"from",
"5",
"-",
"FU",
"treatment",
"."
] | [
{
"id": 0,
"text": "5-FU treatment",
"start": 19,
"end": 23,
"type": "treatment"
},
{
"id": 1,
"text": "5-FU",
"start": 19,
"end": 22,
"type": "drug"
},
{
"id": 2,
"text": "severe toxicities",
"start": 16,
"end": 18,
"type": "effect"
},
{
"... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "risk",
"start": 14,
"end": 15
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"We",
"report",
"a",
"case",
"of",
"reversible",
"encephalopathy",
"syndrome",
"in",
"a",
"16",
"-",
"year",
"-",
"old",
"girl",
"with",
"acute",
"myelogenous",
"leukemia",
"(",
"AML",
")",
",",
"who",
"is",
"undergoing",
"during",
"consolidation",
"chemothe... | [
{
"id": 0,
"text": "reversible encephalopathy syndrome",
"start": 5,
"end": 8,
"type": "effect"
},
{
"id": 1,
"text": "a 16-year-old girl with acute myelogenous leukemia (AML)",
"start": 9,
"end": 23,
"type": "subject"
},
{
"id": 2,
"text": "16-year-old",
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "undergoing",
"start": 26,
"end": 27
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "subject"
},
{
"entity_id": 2,
... |
[
"Concurrent",
"use",
"of",
"vismodegib",
"and",
"warfarin",
"was",
"deemed",
"the",
"probable",
"cause",
"of",
"acute",
"INR",
"elevation",
"in",
"this",
"case",
",",
"suggesting",
"the",
"need",
"for",
"close",
"monitoring",
"of",
"INR",
"values",
"in",
"pa... | [
{
"id": 0,
"text": "vismodegib and warfarin",
"start": 3,
"end": 6,
"type": "treatment"
},
{
"id": 1,
"text": "vismodegib",
"start": 3,
"end": 4,
"type": "drug"
},
{
"id": 2,
"text": "warfarin",
"start": 5,
"end": 6,
"type": "drug"
},
{
"id... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "cause",
"start": 10,
"end": 11
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Captopril",
"is",
"an",
"angiotensin",
"-",
"converting",
"enzyme",
"(",
"ACE",
")",
"inhibitor",
"and",
"their",
"cutaneous",
"side",
"-",
"effects",
"are",
"documented",
",",
"but",
"little",
"has",
"been",
"published",
"concerning",
"the",
"usefulness",
"o... | [
{
"id": 0,
"text": "cutaneous side-effects",
"start": 13,
"end": 17,
"type": "effect"
},
{
"id": 1,
"text": "Captopril",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 2,
"text": "Captopril",
"start": 0,
"end": 1,
"type": "drug"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "documented",
"start": 18,
"end": 19
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,... |
[
"High",
"-",
"dose",
"methylprednisolone",
"in",
"a",
"pregnant",
"woman",
"with",
"Crohn",
"'",
"s",
"disease",
"and",
"adrenal",
"suppression",
"in",
"her",
"newborn",
"."
] | [
{
"id": 0,
"text": "a pregnant woman with Crohn's disease",
"start": 5,
"end": 13,
"type": "subject"
},
{
"id": 1,
"text": "pregnant",
"start": 6,
"end": 7,
"type": "age"
},
{
"id": 2,
"text": "woman",
"start": 7,
"end": 8,
"type": "gender"
},
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "in",
"start": 16,
"end": 17
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "age"
},
{
"entity_id": 2,
"rol... |
[
"Cardiac",
"hypersensitivity",
"and",
"myopericarditis",
"have",
"been",
"reported",
"during",
"long",
"-",
"term",
"treatment",
"with",
"mesalazine",
"."
] | [
{
"id": 0,
"text": "Cardiac hypersensitivity and myopericarditis",
"start": 0,
"end": 4,
"type": "effect"
},
{
"id": 1,
"text": "long-term treatment with mesalazine",
"start": 8,
"end": 14,
"type": "treatment"
},
{
"id": 2,
"text": "long-term",
"start": 8,... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "reported",
"start": 6,
"end": 7
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"It",
"is",
"concluded",
"that",
"'",
"cerebral",
"atrophy",
"'",
"on",
"CT",
"scans",
"may",
"represent",
"an",
"accumulative",
"effect",
"of",
"ACTH",
"and",
"that",
"ACTH",
"should",
"be",
"given",
"with",
"the",
"utmost",
"discretion",
",",
"and",
"in"... | [
{
"id": 0,
"text": "cerebral atrophy",
"start": 5,
"end": 7,
"type": "effect"
},
{
"id": 1,
"text": "ACTH",
"start": 17,
"end": 18,
"type": "treatment"
},
{
"id": 2,
"text": "ACTH",
"start": 17,
"end": 18,
"type": "drug"
},
{
"id": 3,
"... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "represent",
"start": 12,
"end": 13
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Two",
"cases",
"of",
"polymorphic",
"ventricular",
"tachycardia",
"induced",
"by",
"the",
"administration",
"of",
"verapamil",
"against",
"paroxysmal",
"supraventricular",
"tachycardia",
"."
] | [
{
"id": 0,
"text": "polymorphic ventricular tachycardia",
"start": 3,
"end": 6,
"type": "effect"
},
{
"id": 1,
"text": "verapamil",
"start": 11,
"end": 12,
"type": "treatment"
},
{
"id": 2,
"text": "paroxysmal supraventricular tachycardia",
"start": 13,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 6,
"end": 7
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Fatal",
"acute",
"encephalomyelitis",
"after",
"a",
"single",
"dose",
"of",
"intrathecal",
"methotrexate",
"."
] | [
{
"id": 0,
"text": "Fatal acute encephalomyelitis",
"start": 0,
"end": 3,
"type": "effect"
},
{
"id": 1,
"text": "single dose of intrathecal methotrexate",
"start": 5,
"end": 10,
"type": "treatment"
},
{
"id": 2,
"text": "single dose",
"start": 5,
"end... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "after",
"start": 3,
"end": 4
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"The",
"authors",
"report",
"one",
"case",
"of",
"incomplete",
"posterior",
"hyaloid",
"detachment",
"(",
"PHD",
")",
"following",
"intravitreal",
"pegaptanib",
"to",
"treat",
"DME",
"."
] | [
{
"id": 0,
"text": "incomplete posterior hyaloid detachment (PHD)",
"start": 6,
"end": 13,
"type": "effect"
},
{
"id": 1,
"text": "intravitreal pegaptanib",
"start": 14,
"end": 16,
"type": "treatment"
},
{
"id": 2,
"text": "intravitreal",
"start": 14,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "following",
"start": 13,
"end": 14
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Pulmonary",
"edema",
"as",
"a",
"delayed",
"complication",
"of",
"ritodrine",
"therapy",
"."
] | [
{
"id": 0,
"text": "Pulmonary edema",
"start": 0,
"end": 2,
"type": "effect"
},
{
"id": 1,
"text": "ritodrine",
"start": 7,
"end": 8,
"type": "treatment"
},
{
"id": 2,
"text": "ritodrine",
"start": 7,
"end": 8,
"type": "drug"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "complication",
"start": 5,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,... |
[
"Carbamazepine",
"toxicity",
"following",
"Oxybutynin",
"and",
"Dantrolene",
"administration",
":",
"a",
"case",
"report",
"."
] | [
{
"id": 0,
"text": "Oxybutynin and Dantrolene",
"start": 3,
"end": 6,
"type": "treatment"
},
{
"id": 1,
"text": "Oxybutynin",
"start": 3,
"end": 4,
"type": "drug"
},
{
"id": 2,
"text": "Dantrolene",
"start": 5,
"end": 6,
"type": "drug"
},
{
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "following",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Multiple",
"seizures",
"after",
"bupropion",
"overdose",
"in",
"a",
"small",
"child",
"."
] | [
{
"id": 0,
"text": "Multiple seizures",
"start": 0,
"end": 2,
"type": "effect"
},
{
"id": 1,
"text": "bupropion overdose",
"start": 3,
"end": 5,
"type": "treatment"
},
{
"id": 2,
"text": "bupropion",
"start": 3,
"end": 4,
"type": "drug"
},
{
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "after",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Sorafenib",
",",
"a",
"multitargeted",
"kinase",
"inhibitor",
"used",
"for",
"the",
"treatment",
"of",
"unresectable",
"hepatocellular",
"carcinoma",
"and",
"advanced",
"renal",
"cell",
"carcinomas",
",",
"received",
"FDA",
"approval",
"in",
"2005",
"."
] | [
{
"id": 0,
"text": "Sorafenib",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 1,
"text": "a multitargeted kinase inhibitor",
"start": 2,
"end": 6,
"type": "treatment"
},
{
"id": 2,
"text": "Sorafenib",
"start": 0,
"end": 1,
"type": "drug"
... | [
{
"id": 0,
"type": "potential_therapeutic_event",
"trigger": {
"text": "treatment",
"start": 9,
"end": 10
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "treatment"
},
{
... |
[
"Triiodothyronine",
"-",
"induced",
"thyrotoxicosis",
"in",
"ophthalmic",
"Graves",
"disease",
"."
] | [
{
"id": 0,
"text": "Triiodothyronine",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 1,
"text": "ophthalmic Graves",
"start": 5,
"end": 7,
"type": "disorder"
},
{
"id": 2,
"text": "Triiodothyronine",
"start": 0,
"end": 1,
"type": "drug"
},... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "disorder"
},
{
"entity_id": 2,
... |
[
"Bleomycin",
"induced",
"hyperpigmentation",
"with",
"yolk",
"sac",
"tumor",
"."
] | [
{
"id": 0,
"text": "Bleomycin",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 1,
"text": "Bleomycin",
"start": 0,
"end": 1,
"type": "drug"
},
{
"id": 2,
"text": "hyperpigmentation with yolk sac tumor",
"start": 2,
"end": 7,
"type": "effect"
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 1,
"end": 2
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"PURPOSE",
":",
"To",
"describe",
"bilateral",
"corneal",
"endothelial",
"dysfunction",
"in",
"a",
"patient",
"with",
"Parkinson",
"disease",
"who",
"was",
"treated",
"with",
"long",
"-",
"term",
"amantadine",
"."
] | [
{
"id": 0,
"text": "bilateral corneal endothelial dysfunction",
"start": 4,
"end": 8,
"type": "effect"
},
{
"id": 1,
"text": "a patient with Parkinson disease",
"start": 9,
"end": 14,
"type": "subject"
},
{
"id": 2,
"text": "long-term amantadine",
"start":... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "in",
"start": 8,
"end": 9
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "subject"
},
{
"entity_id": 2,
"ro... |
[
"A",
"case",
"of",
"severe",
"acute",
"hepatitis",
"caused",
"by",
"cyproterone",
"acetate",
"in",
"a",
"71",
"year",
"old",
"man",
"with",
"prostatic",
"carcinoma",
"is",
"reported",
"with",
"a",
"review",
"of",
"the",
"literature",
"on",
"hepatic",
"reacti... | [
{
"id": 0,
"text": "acute hepatitis",
"start": 4,
"end": 6,
"type": "effect"
},
{
"id": 1,
"text": "cyproterone acetate",
"start": 8,
"end": 10,
"type": "treatment"
},
{
"id": 2,
"text": "cyproterone acetate",
"start": 8,
"end": 10,
"type": "drug"
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "caused",
"start": 6,
"end": 7
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Insulin",
"-",
"dependent",
"diabetes",
"mellitus",
"associated",
"with",
"danazol",
"."
] | [
{
"id": 0,
"text": "danazol",
"start": 7,
"end": 8,
"type": "treatment"
},
{
"id": 1,
"text": "danazol",
"start": 7,
"end": 8,
"type": "drug"
},
{
"id": 2,
"text": "Insulin-dependent diabetes mellitus",
"start": 0,
"end": 5,
"type": "effect"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "associated",
"start": 5,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"CONCLUSIONS",
":",
"Topical",
"brimonidine",
"may",
"be",
"associated",
"with",
"central",
"nervous",
"system",
"depression",
"in",
"infants",
"."
] | [
{
"id": 0,
"text": "Topical brimonidine",
"start": 2,
"end": 4,
"type": "treatment"
},
{
"id": 1,
"text": "brimonidine",
"start": 3,
"end": 4,
"type": "drug"
},
{
"id": 2,
"text": "Topical",
"start": 2,
"end": 3,
"type": "route"
},
{
"id": ... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "associated",
"start": 6,
"end": 7
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Flecainide",
"-",
"associated",
"pneumonitis",
"with",
"acute",
"respiratory",
"failure",
"in",
"a",
"patient",
"with",
"the",
"LEOPARD",
"syndrome",
"."
] | [
{
"id": 0,
"text": "a patient with the LEOPARD syndrome",
"start": 9,
"end": 15,
"type": "subject"
},
{
"id": 1,
"text": "Flecainide",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 2,
"text": "Flecainide",
"start": 0,
"end": 1,
"type": "drug... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "associated",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Seizure",
"with",
"hyponatremia",
"in",
"a",
"child",
"prescribed",
"desmopressin",
"for",
"nocturnal",
"enuresis",
"."
] | [
{
"id": 0,
"text": "desmopressin",
"start": 7,
"end": 8,
"type": "treatment"
},
{
"id": 1,
"text": "desmopressin",
"start": 7,
"end": 8,
"type": "drug"
},
{
"id": 2,
"text": "nocturnal enuresis",
"start": 9,
"end": 11,
"type": "disorder"
},
{
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "in",
"start": 3,
"end": 4
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
"ro... |
[
"Risks",
"and",
"benefits",
"of",
"co",
"-",
"treatment",
"should",
"be",
"carefully",
"considered",
"and",
"therapeutic",
"alternatives",
"to",
"NSAIDs",
"should",
"be",
"recommended",
"to",
"patients",
"with",
"central",
"DI",
"in",
"order",
"to",
"improve",
... | [
{
"id": 0,
"text": "therapeutic alternatives to NSAIDs",
"start": 12,
"end": 16,
"type": "treatment"
},
{
"id": 1,
"text": "central DI",
"start": 22,
"end": 24,
"type": "disorder"
},
{
"id": 2,
"text": "NSAIDs",
"start": 15,
"end": 16,
"type": "dru... | [
{
"id": 0,
"type": "potential_therapeutic_event",
"trigger": {
"text": "recommended",
"start": 18,
"end": 19
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "disorder"
},
{
... |
[
"She",
"had",
"been",
"treated",
"by",
"Carbamazepine",
"1000",
"mg",
"/",
"day",
"for",
"neuropathic",
"pain",
"for",
"2",
"years",
"without",
"clinical",
"or",
"laboratory",
"signs",
"of",
"toxicity",
"."
] | [
{
"id": 0,
"text": "Carbamazepine 1000 mg/day",
"start": 5,
"end": 10,
"type": "treatment"
},
{
"id": 1,
"text": "neuropathic pain",
"start": 11,
"end": 13,
"type": "disorder"
},
{
"id": 2,
"text": "Carbamazepine",
"start": 5,
"end": 6,
"type": "dr... | [
{
"id": 0,
"type": "potential_therapeutic_event",
"trigger": {
"text": "treated",
"start": 3,
"end": 4
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "disorder"
},
{
"ent... |
[
"The",
"chemotherapeutics",
",",
"including",
"vincristine",
",",
"actinomycin",
"D",
",",
"and",
"epirubicin",
"in",
"case",
"1",
"and",
"vincristine",
"and",
"actinomycin",
"D",
"in",
"case",
"2",
",",
"were",
"given",
"before",
"the",
"hepatotoxicity",
"dev... | [
{
"id": 0,
"text": "vincristine and actinomycin D",
"start": 15,
"end": 19,
"type": "treatment"
},
{
"id": 1,
"text": "vincristine",
"start": 15,
"end": 16,
"type": "drug"
},
{
"id": 2,
"text": "actinomycin D",
"start": 17,
"end": 19,
"type": "drug... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "given",
"start": 24,
"end": 25
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"After",
"a",
"second",
"dose",
"of",
"metoclopramide",
",",
"these",
"symptoms",
"recurred",
"and",
"were",
"associated",
"with",
"confusion",
",",
"agitation",
",",
"fever",
",",
"diaphoresis",
",",
"tachypnea",
",",
"tachycardia",
",",
"and",
"hypertension",
... | [
{
"id": 0,
"text": "second dose of metoclopramide",
"start": 2,
"end": 6,
"type": "treatment"
},
{
"id": 1,
"text": "metoclopramide",
"start": 5,
"end": 6,
"type": "drug"
},
{
"id": 2,
"text": "confusion, agitation, fever, diaphoresis, tachypnea, tachycardia, ... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "associated",
"start": 12,
"end": 13
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"We",
"report",
"the",
"first",
"case",
"of",
"tuberculous",
"uveitis",
"due",
"to",
"etanercept",
"."
] | [
{
"id": 0,
"text": "tuberculous uveitis",
"start": 6,
"end": 8,
"type": "effect"
},
{
"id": 1,
"text": "etanercept",
"start": 10,
"end": 11,
"type": "treatment"
},
{
"id": 2,
"text": "etanercept",
"start": 10,
"end": 11,
"type": "drug"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "due to",
"start": 8,
"end": 10
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Acute",
"hyperphosphatemia",
"caused",
"by",
"sodium",
"phosphate",
"enema",
"in",
"a",
"patient",
"with",
"liver",
"dysfunction",
"and",
"chronic",
"renal",
"failure",
"."
] | [
{
"id": 0,
"text": "Acute hyperphosphatemia",
"start": 0,
"end": 2,
"type": "effect"
},
{
"id": 1,
"text": "sodium phosphate enema",
"start": 4,
"end": 7,
"type": "treatment"
},
{
"id": 2,
"text": "sodium phosphate",
"start": 4,
"end": 6,
"type": "... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "caused",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"We",
"discuss",
"the",
"association",
"between",
"carbamazepine",
"and",
"hyponatremia",
"and",
"the",
"causes",
"of",
"hyponatremia",
"after",
"cardiopulmonary",
"bypass",
"."
] | [
{
"id": 0,
"text": "carbamazepine",
"start": 5,
"end": 6,
"type": "treatment"
},
{
"id": 1,
"text": "carbamazepine",
"start": 5,
"end": 6,
"type": "drug"
},
{
"id": 2,
"text": "hyponatremia",
"start": 7,
"end": 8,
"type": "effect"
}
] | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "association",
"start": 3,
"end": 4
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Use",
"of",
"the",
"Naranjo",
"adverse",
"drug",
"reaction",
"probability",
"algorithm",
"indicated",
"a",
"probable",
"relationship",
"between",
"serotonin",
"syndrome",
"and",
"treatment",
"with",
"lithium",
"and",
"venlafaxine",
"."
] | [
{
"id": 0,
"text": "serotonin syndrome",
"start": 14,
"end": 16,
"type": "effect"
},
{
"id": 1,
"text": "treatment with lithium and venlafaxine",
"start": 17,
"end": 22,
"type": "treatment"
},
{
"id": 2,
"text": "lithium",
"start": 19,
"end": 20,
"... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "a probable relationship between",
"start": 10,
"end": 14
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
... |
[
"The",
"exact",
"mechanism",
"of",
"IVIG",
"-",
"associated",
"acute",
"renal",
"failure",
"remains",
"unclear",
"."
] | [
{
"id": 0,
"text": "IVIG",
"start": 4,
"end": 5,
"type": "treatment"
},
{
"id": 1,
"text": "IVIG",
"start": 4,
"end": 5,
"type": "drug"
},
{
"id": 2,
"text": "acute renal failure",
"start": 7,
"end": 10,
"type": "effect"
},
{
"id": 3,
"... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "associated",
"start": 6,
"end": 7
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"We",
"report",
"on",
"7",
"patients",
"(",
"2",
"women",
",",
"5",
"men",
")",
"with",
"chronic",
"renal",
"failure",
",",
"who",
"developed",
"under",
"a",
"high",
"dosage",
"of",
"the",
"new",
"diuretic",
"muzolimine",
"(",
"range",
"240",
"to",
"14... | [
{
"id": 0,
"text": "a high dosage of the new diuretic muzolimine (range 240 to 1440 mg per day)",
"start": 20,
"end": 37,
"type": "treatment"
},
{
"id": 1,
"text": "diuretic muzolimine",
"start": 26,
"end": 28,
"type": "drug"
},
{
"id": 2,
"text": "per day",
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "developed",
"start": 18,
"end": 19
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"Two",
"renal",
"transplant",
"patients",
"developed",
"anemia",
"during",
"treatment",
"of",
"hypertension",
"with",
"enalapril",
"medication",
"."
] | [
{
"id": 0,
"text": "Two renal transplant patients",
"start": 0,
"end": 4,
"type": "subject"
},
{
"id": 1,
"text": "Two",
"start": 0,
"end": 1,
"type": "population"
},
{
"id": 2,
"text": "renal transplant",
"start": 1,
"end": 3,
"type": "disorder"
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "developed",
"start": 4,
"end": 5
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "population"
},
{
"entity_id": 2,
... |
[
"Sotalol",
"-",
"induced",
"bradycardia",
"reversed",
"by",
"glucagon",
"."
] | [
{
"id": 0,
"text": "glucagon",
"start": 6,
"end": 7,
"type": "treatment"
},
{
"id": 1,
"text": "Sotalol-induced bradycardia",
"start": 0,
"end": 4,
"type": "disorder"
},
{
"id": 2,
"text": "glucagon",
"start": 6,
"end": 7,
"type": "drug"
},
{
... | [
{
"id": 0,
"type": "potential_therapeutic_event",
"trigger": {
"text": "reversed",
"start": 4,
"end": 5
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "disorder"
},
{
"en... |
[
"The",
"development",
"of",
"cutaneous",
"ecchymosis",
"associated",
"with",
"a",
"sudden",
"fall",
"in",
"hemoglobin",
"after",
"the",
"administration",
"of",
"alteplase",
"should",
"strongly",
"suggest",
"the",
"possibility",
"of",
"diffuse",
"subfascial",
"hemato... | [
{
"id": 0,
"text": "cutaneous ecchymosis",
"start": 3,
"end": 5,
"type": "effect"
},
{
"id": 1,
"text": "a sudden fall in hemoglobin",
"start": 7,
"end": 12,
"type": "effect"
},
{
"id": 2,
"text": "diffuse subfascial hematoma",
"start": 23,
"end": 26,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "development",
"start": 1,
"end": 2
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "effect"
},
{
"entity_id": 2,
... |
[
"We",
"report",
"a",
"case",
"of",
"papillary",
"necrosis",
"in",
"a",
"patient",
"treated",
"with",
"indinavir",
"."
] | [
{
"id": 0,
"text": "papillary necrosis",
"start": 5,
"end": 7,
"type": "effect"
},
{
"id": 1,
"text": "indinavir",
"start": 12,
"end": 13,
"type": "treatment"
},
{
"id": 2,
"text": "indinavir",
"start": 12,
"end": 13,
"type": "drug"
},
{
"i... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "treated",
"start": 10,
"end": 11
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"Generalized",
"maculopapular",
"and",
"papular",
"purpuric",
"eruptions",
"are",
"perhaps",
"the",
"most",
"common",
"thionamide",
"-",
"induced",
"reactions",
"."
] | [
{
"id": 0,
"text": "Generalized maculopapular and papular purpuric eruptions",
"start": 0,
"end": 6,
"type": "effect"
},
{
"id": 1,
"text": "reactions",
"start": 14,
"end": 15,
"type": "effect"
},
{
"id": 2,
"text": "thionamide",
"start": 11,
"end": 12... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 13,
"end": 14
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "effect"
},
{
"entity_id": 2,
... |
[
"Imidazoline",
"intoxication",
"due",
"to",
"overdose",
"or",
"accidental",
"ingestion",
"but",
"also",
"after",
"normal",
"therapeutic",
"usage",
"is",
"frequent",
"in",
"children",
"."
] | [
{
"id": 0,
"text": "children",
"start": 17,
"end": 18,
"type": "subject"
},
{
"id": 1,
"text": "children",
"start": 17,
"end": 18,
"type": "age"
},
{
"id": 2,
"text": "Imidazoline",
"start": 0,
"end": 1,
"type": "treatment"
},
{
"id": 3,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "due",
"start": 2,
"end": 3
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "age"
},
{
"entity_id": 2,
"role... |
[
"A",
"50",
"-",
"year",
"-",
"old",
"diabetic",
"and",
"hypertensive",
"male",
"patient",
"is",
"reported",
"who",
"had",
"ticlopidine",
"-",
"induced",
"marrow",
"aplasia",
"partially",
"responsive",
"to",
"colony",
"-",
"stimulating",
"factors",
"and",
"cort... | [
{
"id": 0,
"text": "ticlopidine",
"start": 15,
"end": 16,
"type": "treatment"
},
{
"id": 1,
"text": "ticlopidine",
"start": 15,
"end": 16,
"type": "drug"
},
{
"id": 2,
"text": "50-year-old diabetic and hypertensive male patient",
"start": 1,
"end": 11,... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "induced",
"start": 17,
"end": 18
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "drug"
},
{
"entity_id": 2,
... |
[
"A",
"patient",
"with",
"intracranial",
"osteosarcoma",
"that",
"arose",
"16",
"years",
"after",
"radiation",
"therapy",
"for",
"hereditary",
"retinoblastoma",
"developed",
"fatal",
"cerebral",
"edema",
"and",
"brainstem",
"herniation",
"after",
"she",
"received",
"... | [
{
"id": 0,
"text": "a single dose of intravenous methotrexate",
"start": 25,
"end": 31,
"type": "treatment"
},
{
"id": 1,
"text": "intracranial osteosarcoma",
"start": 3,
"end": 5,
"type": "disorder"
},
{
"id": 2,
"text": "a single dose",
"start": 25,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "developed",
"start": 15,
"end": 16
},
"arguments": [
{
"entity_id": 0,
"role": "treatment"
},
{
"entity_id": 1,
"role": "disorder"
},
{
"entity_id": 2... |
[
"Neutropenia",
"is",
"an",
"infrequent",
"complication",
"following",
"administration",
"of",
"the",
"angiotensin",
"-",
"converting",
"enzyme",
"(",
"ACE",
")",
"inhibitor",
",",
"captopril",
"."
] | [
{
"id": 0,
"text": "Neutropenia",
"start": 0,
"end": 1,
"type": "effect"
},
{
"id": 1,
"text": "the angiotensin-converting enzyme (ACE) inhibitor, captopril",
"start": 8,
"end": 19,
"type": "treatment"
},
{
"id": 2,
"text": "captopril",
"start": 18,
"e... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "following",
"start": 5,
"end": 6
},
"arguments": [
{
"entity_id": 0,
"role": "effect"
},
{
"entity_id": 1,
"role": "treatment"
},
{
"entity_id": 2,
... |
[
"INTRODUCTION",
":",
"We",
"describe",
"the",
"neurointensive",
"care",
"(",
"NIC",
")",
"management",
"of",
"a",
"patient",
"with",
"severe",
"cerebral",
"swelling",
"and",
"raised",
"intracranial",
"pressure",
"(",
"ICP",
")",
"after",
"severe",
"sodium",
"v... | [
{
"id": 0,
"text": "patient",
"start": 13,
"end": 14,
"type": "subject"
},
{
"id": 1,
"text": "severe cerebral swelling and raised intracranial pressure (ICP)",
"start": 15,
"end": 25,
"type": "effect"
},
{
"id": 2,
"text": "intoxication",
"start": 33,
... | [
{
"id": 0,
"type": "adverse_event",
"trigger": {
"text": "after",
"start": 25,
"end": 26
},
"arguments": [
{
"entity_id": 0,
"role": "subject"
},
{
"entity_id": 1,
"role": "effect"
},
{
"entity_id": 2,
... |
End of preview. Expand in Data Studio
README.md exists but content is empty.
- Downloads last month
- 12